Genetic Testing & Diagnostics
Part of Healthcare - Genomics & Precision Medicine
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 NTRA | Natera, Inc. Common Stock | $26.5b | $204.96 | -1.4% | 316.3K |
 LH | Labcorp Holdings Inc. | $21.7b | $274.54 | +0.3% | 167.6K |
 ILMN | Illumina Inc | $18.5b | $127.38 | 0.0% | 424.1K |
 QGEN | QIAGEN N.V. | $8.1b | $40.77 | -0.6% | 293.5K |
 BLLN | BillionToOne, Inc. Class A Common Stock | $3.2b | $83.16 | +4.8% | 160.3K |
 TXG | 10x Genomics, Inc. Class A Common Stock | $2.5b | $22.04 | -1.3% | 824.1K |
 VCYT | Veracyte, Inc. | $2.4b | $32.39 | +0.4% | 123.7K |
 WGS | GeneDx Holdings Corp. Class A Common Stock | $1.7b | $66.61 | +0.6% | 161.6K |
 NEO | NeoGenomics, Inc. | $0.9b | $7.97 | -0.3% | 607.5K |
 AZTA | Azenta, Inc. | $0.9b | $23.05 | +1.9% | 304.2K |
 CDNA | CareDx, Inc. | $0.8b | $18.14 | -0.9% | 90.9K |
 OPK | Opko Health Inc. | $0.8b | $1.19 | +3.9% | 1.6M |
 PSNL | Personalis, Inc. Common Stock | $0.7b | $6.57 | -0.2% | 345.2K |
 FLGT | Fulgent Genetics, Inc. Common Stock | $488.1m | $16.53 | -1.7% | 107.3K |
 MLAB | Mesa Laboratories Inc | $470.0m | $93.39 | +2.5% | 58.8K |
 MYGN | Myriad Genetics Inc | $407.7m | $4.76 | +0.3% | 198.5K |
 PACB | Pacific Biosciences of California, Inc. | $380.5m | $1.40 | +4.1% | 3.9M |
 PRE | Prenetics Global Limited Class A Ordinary Share | $335.7m | $19.41 | -1.4% | 34.1K |
 ALPS | ALPS Group Inc Ordinary Share | $161.7m | $1.01 | +0.5% | 3.0K |
 IMDX | Insight Molecular Diagnostics Inc. Common Stock | $82.0m | $3.38 | -10.1% | 98.0K |
 BNGO | Bionano Genomics, Inc. Common Stock | $12.5m | $1.16 | -3.8% | 76.4K |
 BGLC | BioNexus Gene Lab Corp Common stock | $5.5m | $2.30 | +4.2% | 837 |
 QUCY | Mainz Biomed N.V. Ordinary Shares | $5.2m | $0.47 | +1.5% | 61.5K |